General Information of Drug (ID: DM57GL1)

Drug Name
4-(4-fluoropyrazol-1-yl)-1,2-oxazol-5-amine
Synonyms CHEMBL4166624; BDBM50321330
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Preclinical [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 168.13
Logarithm of the Partition Coefficient (xlogp) 0.1
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 5
Chemical Identifiers
Formula
C6H5FN4O
IUPAC Name
4-(4-fluoropyrazol-1-yl)-1,2-oxazol-5-amine
Canonical SMILES
C1=C(C=NN1C2=C(ON=C2)N)F
InChI
InChI=1S/C6H5FN4O/c7-4-1-9-11(3-4)5-2-10-12-6(5)8/h1-3H,8H2
InChIKey
YCBKZPFCIBXKIG-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
145952699
ChEBI ID
CHEMBL4166624
TTD ID
D9Y2KA
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tryptophan 2,3-dioxygenase (TDO) TTXNCBV T23O_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019 May;18(5):379-401.